Asked whether she knew that Johnson & Johnson, if found liable in this case, might have to pay "upwards of $17 billion to abate the nuisance issue," Diesselhorst said, "I wasn't aware of that."
Johnson & Johnson has denied any wrongdoing, saying it followed the law and acted appropriately in its marketing and promotion of opioids.
With the state resting, Johnson & Johnson will now resume its defense.
She said the company properly trained reps to educate doctors about opioids and said it would be "wrong" for Johnson & Johnson to target pill mills, women and veterans.
Johnson & Johnson attorney Sabrina Strong leaped to object: "Your honor, we've seen this throughout the trial, and I would ask that it stop."